From:  The neurological burden of cirrhosis: a comprehensive clinical review of mechanisms, diagnosis, and management

 Summary of neurological complications in cirrhosis: presentation, diagnostics, and contemporary management.

Neurological complicationPrimary pathophysiologyKey clinical presentationDiagnostic approachContemporary managementKey references
Hepatic encephalopathyNH3 toxicity, neuroinflammation, astrocyte swelling.Cognitive decline, asterixis, altered consciousness, sleep inversion.Clinical grading (West Haven), psychometric tests, EEG.Lactulose, rifaximin, LOLA, BCAAs.[11, 13, 14, 27, 28, 37, 44, 45, 48]
Acquired hepatocerebral degenerationMn accumulation in basal ganglia, dopaminergic dysfunction.Parkinsonism, ataxia, choreoathetosis, intention tremor.Brain MRI (T1-hyperintensity in globus pallidus), blood Mn.Liver transplantation; BRTO.[5, 66, 68, 69, 72, 77]
Hepatic myelopathyPortosystemic shunting, demyelination of corticospinal tracts.Progressive spastic paraparesis, hyperreflexia, minimal sensory loss.Spinal MRI (rule out compression), EMG/nerve conduction.Liver transplantation (early stage); often refractory to standard HE therapies.[4, 97100, 103, 104, 107, 108]
Peripheral neuropathyToxins (alcohol), metabolic derangement, viral (HCV) cryoglobulinemia.Sensorimotor deficits, paresthesias, areflexia, dysautonomia.Nerve conduction studies, autonomic reflex testing (CARTs).Etiology-specific (e.g., DAAs for HCV, alcohol cessation), gabapentinoids.[50, 114117, 119, 120, 123, 124, 128]
Cerebrovascular complicationsPrecarious rebalanced hemostasis, accelerated atherosclerosis, endothelial dysfunction.Focal neurological deficits, signs of ICH or ischemic stroke.Brain CT/MRI. Avoid relying solely on standard PT/INR.Risk-benefit individualized; DOACs for AF (Child A/B only); avoid 4F-PCC.[15, 16, 136, 144]
NeuroinfectionsCirrhosis-associated immune dysfunction (CAID), bacterial translocation.Refractory HE, frequently absent fever/nuchal rigidity.Early LP, multiplex PCR, CSF galactomannan; CLIF-SOFA screening.Broad-spectrum antibiotics tailored to local MDROs, targeted antifungals.[145148, 151154]
Sleep & neuromotor disordersDelayed melatonin clearance, iron/hepcidin dysregulation, energy depletion.Severe insomnia, excessive daytime sleepiness, RLS, muscle cramps.PSQI, actigraphy, clinical history, polysomnography.Light therapy (sleep); baclofen, L-carnitine, pickle juice (cramps); dopamine agonists (RLS).[1820, 23, 168, 170173, 175, 176]

4F-PCC: four-factor prothrombin complex concentrate; AF: atrial fibrillation; BCAAs: branched-chain amino acids; BRTO: balloon-occluded retrograde transvenous obliteration; CARTs: cardiovascular autonomic reflex tests; CLIF-SOFA: Chronic Liver Failure-Sequential Organ Failure Assessment; CSF: cerebrospinal fluid; CT: computed tomography; DAAs: direct-acting antivirals; DOACs: direct oral anticoagulants; EEG: electroencephalogram; EMG: electromyography; HCV: hepatitis C virus; HE: hepatic encephalopathy; ICH: intracranial hemorrhage; INR: international normalized ratio; LOLA: L-ornithine-L-aspartate; MDROs: multidrug-resistant organisms; Mn: manganese; MRI: magnetic resonance imaging; NH3: ammonia; PCR: polymerase chain reaction; PSQI: Pittsburgh Sleep Quality Index; PT: prothrombin time; RLS: restless legs syndrome.